MedTrace Logo

Study on Gynecological Rare Cancers

NCT05733806 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-02-23

No results posted yet for this study

Summary

This is a prospective, observational, multicenter study on gynecological rare tumors.

Conditions

  • Gynecologic Cancer

Interventions

OTHER

chemotherapy, surgery

this is an observational prospective study, therefore no intervention is planned. Patients perform medical and surgical treatment as per standard of case.

Sponsors & Collaborators

  • National Cancer Institute, Naples

    lead OTHER

Principal Investigators

  • Francesco Perrone, MD · IRCCS Fondazione G Pascale, Naples

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-14
Primary Completion
2025-01-01
Completion
2030-02-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05733806 on ClinicalTrials.gov